Octreotide and fatigue 
Octreotide and fatigue Patient Reports February 10, 2010
Octreotide Side Effects Report #5624727-9
Octreotide side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2008. Male patient, weighting 140.0 lb, was diagnosed with carcinoid tumour and was treated with Octreotide. After drug was administered, patient experienced the following side effects: fatigue. Octreotide dosage: unknown. Patient recovered.
Octreotide Side Effects Report #4759063-6
Octreotide side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 30, 2005. Female patient, 76 years of age, weighting 99.21 lb, was diagnosed with carcinoid syndrome and was treated with Octreotide. After drug was administered, patient experienced the following side effects: confusional state, fatigue. Octreotide dosage: 10MG/DAY. Patient recovered.
Octreotide Side Effects Report #5785976-2
Octreotide side effect was reported by a Health Professional from UNITED STATES on June 16, 2008. Female patient, 36 years of age, was diagnosed with carcinoid syndrome and was treated with Octreotide. After drug was administered, patient experienced the following side effects: ataxia
, bradykinesia, cerebellar syndrome, clumsiness, dyskinesia, dysphonia, fatigue, gait disturbance, hyperreflexia. Octreotide dosage: 20 MG EVERY 4 WEEKS. During the same period patient was treated with OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE. Patient recovered.Octreotide Side Effects Report #5967624-1
Octreotide side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 14, 2008. Female patient, 36 years of age, was diagnosed with carcinoid syndrome and was treated with Octreotide. After drug was administered, patient experienced the following side effects: ataxia
, bradykinesia, cerebellar syndrome, clumsiness, dyskinesia, dysphonia, fatigue, gait disturbance, hyperreflexia. Octreotide dosage: 20 MG EVERY 4 WEEKS. During the same period patient was treated with OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE. Patient recovered.